Researchers typically Examine its efficacy and safety profile to other SARMs, noting its favorable tolerability and possible therapeutic purposes in muscle losing and sarcopenia.Coadministration in the sturdy CYP3A4 inhibitor itraconazole experienced nominal effect on the pharmacokinetics of enobosarm and enobosarm glucuronide, whereas the powerful